Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Dec 12, 2007 by Edgar Snyder

Epilepsy Drugs Get New Warnings

Epilepsy drugs

New warning labels will be issued for drugs used to treat epilepsy, according to the Food and Drug Administration (FDA). Brand name epilepsy drugs such as Carbatrol, Tegretol, and Equetro may lead to a rare skin disorder, warranting a change in the current warning on the drugs.

Carbatrol, Tegretol, and Equetro are known generically as carbamazepine. The drugs are used to treat epilepsy, as well as bipolar disorder and nerve pain. Side effects include skin conditions such as epidermal necrolysis and Stevens-Johnson syndrome, which may result in blisters, fever, itching, and lesions.

The FDA has announced that drugs made with carbamazepine will now prominently feature this information in pre-existing black box labels warnings about the risk of anemia. The drugs will also feature warnings specific to people of Asian ancestry, where the occurrence of the skin condition side effects are estimated to be 10 times greater.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Maryland, Ohio, Virginia, and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "FDA Strengthens Warnings On Some Epilepsy Drugs." By Jennifer Corbett Dooren. Wall Street Journal. December 12, 2007.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe